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ABSTRACT: Carbohydrate-binding modules (CBM) play
important roles in targeting and increasing the concentration
of carbohydrate active enzymes on their substrates. Using NMR
to get the solution structure of CBM14, we can gain insight into
secondary structure elements and intramolecular interactions
with our assigned nuclear overhauser effect peaks. This reveals
that two conserved aromatic residues (Phe437 and Phe456)
make up the hydrophobic core of the CBM. These residues are
also responsible for connecting the two β-sheets together, by
being part of β2 and β4, respectively, and together with disulfide
bridges, they create CBM14’s characteristic “hevein-like” fold.
Most CBMs rely on aromatic residues for substrate binding;
however, CBM14 contains just a single tryptophan (Trp465)
that together with Asn466 enables substrate binding. Interestingly, an alanine mutation of a single residue (Leu454) located
behind Trp465 renders the CBM incapable of binding. Fluorescence spectroscopy performed on this mutant reveals a
significant blue shift, as well as a minor blue shift for its neighbor Val455. The reduction in steric hindrance causes the
tryptophan to be buried into the hydrophobic core of the structure and therefore suggests a preorganized binding site for this
CBM. Our results show that both Trp465 and Asn466 are affected when CBM14 interacts with both (GlcNAc)3 and β-chitin,
that the binding interactions are weak, and that CBM14 displays a slightly higher affinity toward β-chitin.
■ INTRODUCTION
Protein−carbohydrate interactions are involved in numerous
biological processes, such as cell−cell recognition, fertilization,
embryogenesis, and tumor metastasis among others.1 Proteins
involved in such interactions often have noncatalytic modules
called carbohydrate-binding modules (CBMs). CBMs are
subdivided into families according to their amino acid
sequence similarity. They are currently classified into seven
“fold families”, which are further divided into three types. Type
A binds to crystalline surfaces, B to glycan chains, and C to
short oligosaccharides.2 CBMs also show different ligand
specificities, and there are characterized CBMs that interact
with chitin, cellulose, starch, and other substrates.3
Chitin or β-1,4-linked N-acetylglucosamine (GlcNAc) is a
linear and water-insoluble polymer that is an abundant
component in the cell walls of fungi and the exoskeleton of
crustaceans (i.e., crab, shrimp, and insects).4 Chitin is not
produced by mammals, making the polymer a likely candidate
to trigger an innate immune response.5 Lectins and other
defense proteins are known to play an important role in
initiating this immune response. Carbohydrate active enzymes
contain many members, among them are chitinases that
catalyze the hydrolysis of chitin. Chitinases are synthesized by
both animals and plants that are not able to produce chitin,
which underlines their importance in their immune defense
and thus their ability to survive.6
In humans, two active chitinases have been reported:
chitotriosidase-1 (CHIT1) and acidic mammalian chitinase.
In addition, a chitobiase is synthesized that catalyzes the
hydrolysis of a soluble GlcNAc dimer.7,8 CHIT1 is synthesized
as a 50 kDa soluble protein able to hydrolyze chitin.9 This
human chitinase is classified as belonging to family 18 of
glycosyl hydrolases (GH18) in the Carbohydrate-Active-
enZymes (CAZy) database (http://www.cazy.org).10 It
consists of two domains: a catalytic domain that adopts the
conserved (α/β)8 TIM barrel form typical for GH18 and a
noncatalytic domain in the N-terminal belonging to a CBM in
family 14 (CBM14), which many of its members are known to
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bind chitin according to the CAZy database. These two
domains are separated by a proline-rich and extended linker
(PT-linker) that comprises 31 residues. The flexible nature of
this linker could suggest that CBM14 works as a guiding
system for CHIT1.11 CBM family 14 has a lectin-like property
of binding small sugars (mono-, di-, and trisaccharides) and is
characterized by its highly conserved “hevein-like” fold.3 The
structure has three disulfide bonds that are important for its
structural integrity as found by site-directed mutagenesis of
either of the cysteins involved. It has also been shown that
removal or mutagenesis of its only tryptophan has a
detrimental effect on the CBMs ability to bind chitin.12,13
Moreover, CHIT1 with its CBM degrades chitin faster and
much more efficiently than its isoform without the CBM.14
According to CAZy, there are currently seven structures of
CBM14s. Only two of the structures have been solved using
NMR and correspond to tachycitin (PDB ID: 1DQC)15 and
dust mite allergen Blo t 12 (PDB ID: 2MFK). The remaining
structures have been solved using X-ray crystallography, among
which are CHIT1 (PDB ID: 5HBF) that includes the CBM14
elucidated by NMR here, Der p 23 (PDB ID: 4ZCE), a dust
mite allergen from Dermatophagoides pteronyssinus,16 and
PfAvr4 (PDB ID: 4Z4A), an effector protein from the tomato
pathogen Pseudocercospora fuligena.17 A structural homolog of
PfAvr4 and CfAvr4, an effector protein from the tomato
pathogen Cladosporium fulvum, has recently18 been co-
crystalized with a chitin hexaoligosaccharide (GlcNAc)6
(PDB ID: 6BN0). This is the first co-crystal structure of a
CBM14 with an oligosaccharide. CfAvr4 has an extended
binding surface that can accommodate longer polysaccharide
chains and the interaction with the substrate is through
aromatic residues and hydrogen bonds, which is more
reminiscent of a type B CBM than the type C common for
CBM14s.3 This protein contains an extended loop that
hydrogen-bonds with the oligosaccharide, as well as linking
an additional N-terminal α-helix to the first β-sheet. It also
contains two residues (Gln69 and Lys84) that through
mutation studies are shown to have a great effect on the
binding. These aspects are not conserved in other CBM14s
and can therefore explain the observed difference in binding
mode.
We have used NMR spectroscopy to determine the solution
structure of CBM14 from CHIT1. As a result, we have
developed further insight into the structural elements
important in keeping CBM14s binding affinity for chitin.
This CBM shows a binding affinity toward both (GlcNAc)3
and β-chitin, and through our studies, we have found that the
same residues (Trp465 and Asn466) are involved in binding
both substrates. However, a single mutation of Leu454 to
alanine renders the CBM unable to bind. Leu454 does not
show a significant change in chemical shift perturbation when
CBM14 (wild type, wt) interacts with either substrates.
Interestingly, with fluorescence spectroscopy, we observe that
Leu454Ala displays a significant blue shift, meaning that the
position of Leu454 in the protein structure is significant for the
correct orientation of Trp465 and therefore the protein’s
ability to bind substrates.
■ RESULTS
Solution Structure of CBM14. The solution structure of
CBM14 (PDB ID: 6SO0) was determined by NMR spectros-
copy. Assignment of the backbone and side-chain chemical
shifts for CBM14 are essentially complete (N, HN, Cα, Hα, and
C′ > 92%; H and C side chains > 76%) (Figure S1). The
mature protein contains the following amino acids for
purification purposes: three extra amino acids (Gly-Ser-Pro)
at the N-terminus and five extra amino acids (Gly-Leu-Val-
Pro-Arg) at the C-terminus. Gly-Ser in the N-terminus have
not been assigned. Due to their location in a flexible-loop
region, Cys460 and Cys462 are not observed because of line
Figure 1. NMR solution structure of CBM14. Backbone representation of the 20 conformers with the lowest CYANA target function. The X-ray
structure (PDB ID: 5HBF) is highlighted in blue. By aligning the X-ray structure with the 20 conformers determined by NMR spectra, the
calculated RMSD is 1.59 Å over residues involved in β-sheets (Table S2).
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broadening. Chemical shift data have been deposited at the
Biological Magnetic Resonance Data Bank (BMRB) under the
accession number 27277. The restraints and structural statistics
for the 20 best conformers of CBM14 are given in Table S1.
The nuclear overhauser effect spectroscopy (NOESY)
experiments show that the CBM14 fold comprises two β-
sheets, three antiparallel β-strands in the N-terminal region
(β1, β2, β3; residues 426−430, 436−442, and 444−449), and
two antiparallel β-strands in the C-terminal region (β4, β5;
residues 455−456 and 463−465). This fold pattern matches
the previously described distorted β-sandwich fold in the
crystal structure of the same protein,11 and is known as the
“hevein-fold”. However, the two structures differ in the amount
of amino acids involved in each β-strand (Table S2).
By aligning the NMR structure with the crystal structure
(Figure 1), we obtain a root-mean-square deviation (RMSD)
of 1.59 Å over the secondary structure (3.78 Å over 48 CA
residues). The highest deviations are observed in the loop
regions of the CBM.
Connecting β2 and β3 is a type I turn (residues 442−444).
The protein contains six cysteins that form three disulfide
bridges (Cys420-Cys440, Cys450-463, and Cys460-462) that
have a stabilizing effect on the β-sandwich, also described by
Fadel et al.11 Through the NOESY experiments, we observed
NOEs between two aromatic residues Phe437 and Phe456
involved in β2 and β4, respectively. These residues create a
hydrophobic core holding the two β-sheets together. This core
is probably essential for the β-sandwich fold given the
conservation of aromatic residues in this position in other
CBM14s.
Interaction with (GlcNAc)3. The binding properties of
CBM14 and (GlcNAc)3 were investigated using isothermal
titration calorimetry (ITC). The shape of the ITC binding
curve is described by the so-called Wiseman c value,19 which
can be expressed as follows
= [ ]c nK Ma t (1)
where n is the stoichiometry of the reaction, Ka is the
equilibrium binding association constant, and [M]t is the
protein concentration. It is well established that c values within
the range of 10 < c < 1000 are a prerequisite for meaningful
calculations of Ka.
19 A Kd of 9.9 mM (Ka = 100 M
−1) has
previously been observed by Crasson et al.13 With a protein
concentration of 45 μM, typical for an ITC experiment, it is
suggested that the c value would be close to 0.05. It has been
shown that binding thermodynamics can be obtained even if c
is in the range of 0.01 < c < 10 if a sufficient portion of the
binding isotherm is used for analysis.20 This is achieved by
ensuring a high molar ratio of ligand versus protein at the end
of the titration, accurate knowledge of the concentrations of
both ligand and receptor, an adequate level of signal-to-noise
ratio in the data, and known stoichiometry. Using this
approach, the fit of theoretical data to the experimental data
(Figure S2) for four independent measurements yielded a Kd
of 3.1 ± 0.2 mM and a ΔHr° of −1.6 ± 0.2 kcal/mol.
Moreover, a ΔGr° of −3.3 ± 0.1 kcal/mol and a ΔSr° of 6 ± 1
cal/kmol (−TΔSr° = −1.7 ± 0.2 kcal/mol) can be calculated
from eq 2. The obtained Kd is close to that previously
observed.
Δ ° = Δ ° − Δ ° = − =G H T S RT K RT Kln lnr r r a d (2)
Interaction Studies by NMR. To investigate whether
binding of a different substrate, β-chitin, behaved in the same
way as (GlcNAc)3, we performed
15N-heteronuclear single-
Figure 2. (a) 15N-HSQC of the side chain of Trp465 and Asn466 of CBM14. The arrows indicate the direction in the change in chemical shift of
CBM14 interacting with (GlcNAc)3 (red) and β−chitin (turquoise and purple). This could suggest an increase in binding affinity for the crystalline
substrate. (b) Surface representation of CBM14 showing Trp465 and Asn466 in blue.
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quantum correlation (HSQC) experiments on CBM14 alone
and CBM14 together with β-chitin. This allowed us to
investigate the chemical shift perturbation to probe the
residues involved by comparing the 15N-HSQC spectra of
the protein before and after addition of substrate (Figure S3).
The 15N-HSQC spectrum shows the cross-peaks of the amide
nitrogens and amide hydrogens and is often referred to as the
protein’s “fingerprint” spectrum. Upon substrate binding, the
environment around the nuclei that interact changes and, as a
result, the corresponding cross-peak in 15N-HSQC will change.
The residues with the highest changes in chemical shift
perturbation often belong to the binding site. The biggest
differences observed in chemical shifts belong to the side chain
of Trp465 (Hε1/Nε1) and Asn466 (Hδ1/Nδ1 and Hδ2/Nδ2),
corresponding to the interaction surface of the protein. Both
have previously been described as most perturbed upon
titration with (GlcNAc)3.
13 An overlay of 15N-HSQC for the
side chain of Trp465 and Asn466 for CBM14 interacting with
(GlcNAc)3 and β-chitin is given by Figure 2 (the diagram
comparing all residues is given in Figure S3). The chemical
shift perturbation for CBM14 interacting with 6 mg β-chitin is
not included as the signals in the 15N-HSQC were broadened
beyond detection. As the chemical shift perturbation is more
pronounced for β-chitin, it could indicate a stronger binding
affinity compared to the soluble (GlcNAc)3.
Another residue that shows a chemical shift perturbation is
Thr464. Mutational studies have been done on this threonine
and showed medium impact on binding activity for Thr464,
which could indicate that this residue could be one of the key
polar residues that are directly involved in binding.13
Furthermore, Cys450 and Cys463 also show a minor change
in chemical shift. These cysteins create a disulfide bridge
linking the two β-sheets together.
To allow us to obtain detailed information about the bound
sugar, we performed T1rho NMR spectroscopy on the CBM14-
(GlcNAc)3 system using different protein:ligand concentra-
tions. The resulting one-dimensional (1D) 1H NMR spectra
are given in Figure S4. Compared to the reference spectrum,
the T1rho experiment will display a reduction in signal intensity
if the protein and substrate are bound because the protein’s
relaxation will be observed on the substrate. We observe
indications of substrate binding by getting a reduction in signal
intensity for the methyl groups, H1, H2−H6 for (GlcNAc)3. It
is evident that CBM14 interacts with (GlcNAc)3 and the
nonreducing end of the trimer seems to be preferred (Figure
S4). By knowing the binding site (Trp465 and Asn466) in
CBM14, we were able to use a docking algorithm
(HADDOCK, high-ambiguity driven docking). This showed
that the lowest-energy cluster of CBM14 and (GlcNAc)3
coincide with the affected chemical shifts in the T1rho
experiments (Figure S4). We also tried to probe the interaction
using a water LOGSY21,22 experiment, but due to the Hβ of
the reducing end of (GlcNAc)3 being too close to the
frequency for the saturation of the water signal, the spectrum
was inconclusive. To support the indicated interactions in the
T1rho experiment, we also did a saturation transfer difference
(STD)23,24 experiments varying the protein:ligand concen-
trations, temperature, saturation times, and on-resonances.
However, no detailed information could be extracted from
these spectra.
Leu454Ala Mutant. Looking from a structural point of
view, this leucine is positioned close to the binding site
(Trp465 and Asn466) by β-sheet 2 (β4 and β5). According to
a multiple sequence alignment done using Clustal Omega
(1.2.4) given by Figure 3, we observe that this particular
leucine is conserved in tachycitin, PfAvr4 and CfAvr4. These
Figure 3. (a) One of the conformers of the NMR structure of CBM14 with labeled disulfide bridges (orange) and β-strands. The wheat color in
both terminals corresponds to the residues added for purification purposes. Residues of particular interest includes their side chain and are
highlighted in cyan (except for Asn466 which is added for its involvement in binding the substrate). (b) Multiple-sequence alignment performed
using Clustal Omega (1.2.4) compares CBM14 from HCHT with five other CBM14s. Their sequence is collected from the Protein Data Bank
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proteins also have an aromatic residue (tryptophan or
tyrosine) in the same position as CBM14’s Trp465.
To obtain insight into the differences between CBM14 wild
type and CBM14 Leu454Ala mutant, we produced a 15N-
labeled mutant and recorded a 15N-HSQC spectrum. The
differences in chemical shift compared to the wild type are
showed in Figure 4. With a threshold of Δδ 0.2 ppm, five
residues showed a significant change in chemical shift. Divided
into two groups: Δδ 0.2−0.4 ppm (Thr452, Hε1/Nε1 Trp465
and Hδ1/Nδ1 and Hδ2/Nδ2 Asn466) and Δδ 0.4−0.8 ppm
(Val455 and Thr464). This mutant has previously been
investigated using far-UV CD spectra and β-lactamase
enzymatic activity assays,13 where the conclusion was that
CBM14-Leu454Ala demonstrated a reduced chitin-binding
affinity compared to the wild type. To investigate this
interaction further, we recorded a 15N-HSQC spectrum after
addition of (GlcNAc)3. This addition had no effect on the
chemical shifts. The interaction was also probed by adding β-
chitin, with the same result.
Fluorescence Spectroscopy. Taking advantage of the fact
that CBM14 only has one tryptophan (Trp465), we monitored
the structural impact of alanine substitutions on key binding
residues using fluorescence spectroscopy. The maximum
emission wavelength (λmax) provides a measure of the protein’s
water exposure. The resulting λmax for native CBM14 wild type
(wt), denatured (6 M guanidinium chloride), and its mutants
are given in Figure 5.
The λmax of the native CBM14 is 353.21 nm, which is
explained by the high exposure of Trp465 to the aqueous
solvent. Most of the mutants have a similar λmax compared to
the native form of CBM14, indicating that an alanine
substitution does not modify significantly the direct environ-
ment of the Trp465.
A significant blue shift is observed for CBM14-Leu454Ala
and to a lesser extent for CBM14-Val455Ala. Both residues are
located behind Trp465. A slight blue shift is also observed for
CBM14-Pro451A, which can be explained by its position
behind the Leu454 and/or its implication in the loop
formation (Pro451, Thr452, Gly453, and Leu454). A slight
Figure 4. Surface representation of CBM14 showing the residues affected by mutation of Leu454 - > Ala454. The changes are divided into two
groups: Δδ 0.2−0.4 ppm (orange): Thr452, side chains of Trp465 and Asn466 and Δδ 0.4−0.8 ppm (green): Val455 and Thr464.
Figure 5. Representation of λmax values of native CBM14 wt, its alanine mutants, and its partially denatured form. The blue and red shifts are
represented at the left part (blue) and right part (red) of the diagram. The center of the diagram is aligned to the λmax of CBM14 wt. A structural
representation of the residues showing a significant shift are given to the left of the diagram. The residues inducing a blue shift after alanine
substitution are colored in blue (Pro451Ala, Leu454Ala, and Val455Ala), and substituted residues inducing a red shift are colored in red
(Thr464Ala and Asn466Ala). Disulfide bonds are colored in black and Trp465 in purple.
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red shift is observed for CBM14-Thr464Ala and CBM14-
Asn466Ala. This suggests that Trp465 is more exposed to the
aqueous solvent in the mutant compared to the wild type due
to the smaller side chain of alanine. The highest λmax (354.01
nm) is obtained for the partially denatured sample of CBM14
in 6 M guanidinium chloride.
■ DISCUSSION
Here, we have focused on the solution structure of CBM14
solved by NMR and how this protein interacts with (GlcNAc)3
and β-chitin. This has led to information about structural
elements of this CBM that are vital for its binding affinity. Of
particular interest is Leu454, which is important for orienting
the main binding residue Trp465 correctly. Both residues, as
well as the two aromatic residues creating the hydrophobic
core are conserved in other CBM14s, indicating that these
residues create a preorganized binding site for the substrate.
Use of NOESY experiments enables observation of a cross-
peak between two hydrogen atoms if they are separated by a
distance up to 5 Å.25 This gives rise to a direct determination
of the secondary structure of the protein and therefore
differences in the residues involved in the β-strands for the X-
ray and NMR structures. Together with the three disulfide
bridges, the β-sheets maintain the functional conformation of
the CBM. Furthermore, the NOESY experiments show NOEs
between Phe437 and Phe456. Phe437 is conserved in Der p 23
and tachycitin, but is replaced by a tyrosine in CfAvr4, PfAvr4,
and Blo t 12, whereas Phe456 is conserved in Blo t 12, replaced
by tyrosine in tachycitin and tryptophan in the three other
proteins. These hydrophobic residues that are part of β2 and
β4 are commonly found at these positions (except for Blo t 12
where they are part of β4 and β6) and presumably help linking
the β-sheets together. This suggests that the two aromatic
residues are creating a hydrophobic core that helps stabilize the
structure. Altogether, these aspects give rise to the hevein-like
fold characteristic for CBM14.
Another trait in CBM14, as with most other CBMs, is that it
relies on aromatic residues (often tryptophans) for substrate
binding.3 This CBM14 contains a single tryptophan (Trp465)
located on the protein surface in the C-terminus and makes up
the binding site for chitin together with Asn466.13 The
tryptophan plays a second role for this CBM by being part of
β5 (residues: Cys463-Thr464-Trp465) that is connected to the
N-terminal by a disulfide bridge (Cys450-Cys463) and a loop.
In this loop region is Leu454 that, together with Val455, was
shown to be involved in a hydrophobic pocket important for
chitin binding.13 It is likely that Val455, which is included in
the same β-sheet as Phe456 (β4), and displays NOEs to
Thr464 (in β5), also assists in the structural integrity of this
CBM. This valine is not conserved in other CBM14s and
might not play a significant role in the stabilization of the
structure, but its neighbor, Leu454, is conserved in the
CBM14s that contain an aromatic residue in the same position
as our Trp465 (Figure 3).
By looking at the chemical shift perturbation in the 15N-
HSQC between the mutant Leu454Ala and wild type, both
Val455 and Thr464 display significant changes in chemical
shifts. This and the fact that we do not observe any binding
activity to either (GlcNAc)3 or β-chitin suggest a disrupted
conformation of the CBM and therefore an altered exposure of
Trp465 on the protein surface. The importance of Leu454 for
the correct positioning of Trp465 is strengthened by the
fluorescence spectroscopy data. A significant blue shift is
observed for the Leu454Ala mutant, indicating that the
tryptophan is less exposed to the surface. When substituted
into alanine, the steric hindrance around Trp465 is reduced
and leaves more space for this residue to be more buried into
the structure of the hevein-like fold. We also observe a smaller
blue shift for Val455Ala and Pro451Ala that supports this
theory due to their position (right behind Trp465 and in the
loop formation, respectively) in this CBM. This indicates that
CBM14 could have a preorganized binding site, which means
that the role of the hevein-like fold is to keep the tryptophan
correctly oriented for efficient substrate binding.
CBM14 is classified as a type C CBM,3 and it is therefore
able to bind short-chain oligosaccharides as also shown by
Crasson and co-workers.13 Out of the tested oligosaccharides,
they found that CBM14 had the highest affinity toward
(GlcNAc)3. Additionally, this CBM has previously shown a
strong affinity for α-chitin,26 which complements our findings
of its ability to bind β-chitin. However, the ability to bind
crystalline substrate is a feature that is characteristic of type A
CBMs that exhibit a platform-like binding site able to
accommodate a crystalline substrate.3 Interestingly, a compar-
ison of the substrates (GlcNAc)3 and β-chitin shows that the
same residues in CBM14 are affected upon substrate binding.
The importance of the polar residues below Trp465, which
participate in hydrogen bonding with the polar groups of the
polysaccharide, for substrate interaction is supported by the
observed change in chemical shift for Thr464. We also observe
a minor change in chemical shift for Cys450 and Cys463
(disulfide bridge). Even though these amino acids are not
located directly below the binding site, the disulfide bridge
they create is pivotal for keeping the structural integrity of the
protein intact for binding.
Studies of CBM14’s ability to bind chito-oligosaccharides
have shown that CBM14 have the best affinity for (GlcNAc)3
(Kd = 9.9 ± 0.8 mM).
13 Our investigation using ITC
demonstrated a dissociation constant in the same range with
a measured Kd of 3.1 ± 0.2 mM. These Kd’s indicate a weak
binding affinity to (GlcNAc)3. By comparing the
15N-HSQC of
the side chains of Trp465 and Asn466 of CBM14 when it
interacts with (GlcNAc)3 or β-chitin (Figure 2), we observe an
increase in chemical shift perturbation for the latter. This
indicates that CBM14 has a stronger binding affinity toward
crystalline substrate compared to the previously observed
soluble oligosaccharides.13
The relatively weak (GlcNAc)3 binding to CBM14 enabled
investigation using T1rho experiments. In Figure S4, we observe
a decrease in signal intensity for the methyl groups, H1, and
H2−H6 for (GlcNAc)3 in the T1rho experiment, all indicating
binding. Ideally, the T1rho spectra could indicate a difference in
the trimer’s orientation upon binding with CBM14 by giving
differences in intensity for the sugar signals. From the
experiments shown in Figure S4, we see that the nonreducing
end seems to be preferred. This was further tested by using the
restraints from the chemical shift perturbation, where Trp465
and Asn466 compose the binding site of CBM14 and a model
of the trimer as input in a HADDOCK algorithm. The best
model generated supports the observations from the T1rho
experiments and suggests a CH−π interaction between the
second sugar ring and the side chain of Trp465 (Figure S5).
Even though weak interactions are favored in saturation
transfer-based experiments like STD-NMR, detailed informa-
tion about the (GlcNAc)3 interaction with CBM14 could not
be acquired due to spillover from the saturation of the methyl
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region of the protein to the methyl groups of (GlcNAc)3. We
have also tried to quantify the binding kinetics (on/off rate)
using stopped-flow spectrophotometry, but the reaction was
too fast for obtaining kinetic details.
It has previously been suggested11 that this CBM14
functions as a guiding system for its catalytic domain. Having
a CBM help concentrate enzymes onto their substrate is a trait
that can be found in other enzyme−CBM systems.27−30 This
can explain the weak binding affinity showed by this CBM as
well as its fast on/off rate. A relatively weak binding and an
innate fast on/off rate would be beneficial for CBM action.
CBMs cannot disrupt the crystalline surface and by this alter
the binding interactions resulting in a decreased binding
affinity as observed for, e.g., GHs. Here, productive binding
yielding hydrolysis reduces the number of binding interactions
and greatly weakens the affinity.31−33
■ MATERIALS AND METHODS
Protein Production and Purification. 13C, 15N, and 15N
CBM14 samples were expressed in Escherichia coli BL21
(DE3) cells. Precultures were grown in Lysogeny broth (LB)
medium (10 g/L tryptone, 5 g/L yeast extract, and 5 g/L
NaCl) supplemented with 50 μL of kanamycin (50 mg/mL) in
a shaking incubator at 30 °C, 225 rpm overnight. Four flasks
with 500 mL of LB media and 500 μL of kanamycin (50 mg/
mL) in each were inoculated with 1% (v/v) of the overnight
culture and grown in a shaking incubator at 30 °C, 225 rpm to
OD600 ≈ 0.9 before cooled on ice for 10 min. The cultures
were centrifuged (Sorvall) at 4 °C, 6150g, for 10 min, and the
cells were resuspended on ice in 450 mL of M9 media (6 g/L
Na2HPO4, 3 g/L KH2PO4, 0.5 g/L NaCl) supplemented with
500 μL of kanamycin (50 mg/mL), 1.0 g of (15NH4)2SO4, 3 g
of glucose (15N label)/2 g of 98% 13C6-D-glucose (
13C, 15N
label) in 10 mL of Milli-Q water, 50 mL of Spectra 9
(Cambridge Isotope Laboratories, Tewksbuty, MA), 5 mL of
Gibco MEM Vitamin Solution (100×), 1 mL of 1 M MgSO4,
and 5−10 mL of trace-metal solution (0.1 g/L ZnSO4, 0.8 g/L
MnSO4, 0.5 g/L FeSO4, 0.1 g/L CuSO4, 1 g/L CaCl2).
After media change, the expression was induced with
isopropyl-1-thio-β-D-galactopyranoside to a final concentration
of 1 mM and incubated at 16 °C, 225 rpm, for 20 h. The cells
were harvested by centrifugation (Sorvall) at 4 °C, 5000g, 10
min. Resuspension of the pellet was done in 40 mL of TES
buffer at pH 8.0 (3.63 g/L TRIS, 1.86 g/L ethylenediaminete-
traacetic acid, 200 g/L sucrose) together with 1/2 tablet
cOmplete ULTRA protease inhibitor (Roche) before proceed-
ing with centrifugation (Sorvall) at 4 °C, 6150g, 20 min. After
removal of supernatant, the cells were incubated at room
temperature for 10 min and then resuspended in 30 mL of MQ
and 1/2 tablet cOmplete ULTRA protease inhibitor (Roche).
The suspension was added to 125 μL of 1 M MgSO4 before
the final centrifugation (Sorvall) at 13 000g, 45 min. The
supernatant was filtered through a 0.2 μm Sterile-flip filter unit
(Nalgene).
Purification of the protein was done on an ÄKTA FPLC
instrument equipped with an anion exchange column (1 mL
HisTrap, FF, GE Healthcare Life Sciences) with a flow rate of
1 mL/min after the following measures: The column was
equilibrated with five column volumes (CV) of equilibration
buffer at pH 8.0 (300 mM KCl, 50 mM KH2PO4, 5 mM
imidazole). The periplasmic extract was loaded onto the
column and unbound protein was removed by 6 CV
equilibration buffer followed by 6 CV washing buffer at pH
8.0 (300 mM KCl, 50 mM KH2PO4, 10 mM imidazole). The
protein was eluted with elution buffer at pH 8.0 (300 mM KCl,
50 mM KH2PO4, 250 mM imidazole). Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis was used to confirm the
separation and purity of the mature CBM14.
The fractions were then combined and dialyzed (MWCO
6−8 kDa) with desalting buffer pH 8.0 (20 mM TRIS, 50 mM
NaCl) (2 h + overnight) and thrombin digestion buffer pH 8.0
(20 mM TRIS, 50 mM NaCl, 5 mM CaCl2) (2 h + 2 h).
The isolated CBM14 was released from the carrier protein
by thrombin cleavage (2−3 U thrombin pr mg protein) at
room temperature, 3−4 rpm for 2 h before adding cOmplete
ULTRA protease inhibitor (Roche).
An ÄKTA FPLC instrument equipped with a size-exclusion
chromatography (SEC) column (HiLoad Superdex 75 pg) was
equilibrated with SEC-buffer at pH 7.5 (20 mM TRIS, 50 mM
NaCl) for 20 h. The flow rate was 1 mL/min. Fractions
containing CBM14 were concentrated and buffer-exchanged
into the NMR buffer (50 mM sodium phosphate, pH 5.5 or
pH 7.0) for interaction studies. Samples for NMR were made
with CBM14 in NMR buffer with D2O added to a final ratio of
90% H2O/10% D2O) by centrifugation using Vivaspin 6
protein spin concentrators (MWCO 3 kDa, Sartorius) at 10
°C, 7000g.
Generation of Mutants of CBM14. Alanine mutants of
CBM14 were generated as previously described by Crasson
and co-workers.13 The 15N CBM14 Leu454Ala mutant was
produced and purified as described above.
NMR Spectroscopy. All CBM14 NMR samples were
prepared in 50 mM sodium phosphate buffer and 10% D2O,
pH 5.5 or pH 7.0 (interaction studies).
The spectra were recorded at 25 °C on a Bruker Ascend 800
MHz spectrometer Avance III HD (Bruker Biospin) equipped
with a 5 mm Z-gradient CP-TCI (H/C/N) cryoprobe at the
NV-NMR-Centre/Norwegian NMR Platform at NTNU
Norwegian University of Science and Technology, Trondheim,
Norway. 1H shifts were referenced internally to the water
signal, while 13C and 15N chemical shifts were referenced
indirectly to HDO based on the absolute frequency ratios.34
Backbone and side-chain assignments of CBM14 were
achieved using 15N-HSQC, 13C-HSQC, HNCA, HN(CO)CA,
HNCO, HN(CA)CO, HNCACB, HN(CO)CACB, H(C)CH-
TOCSY, H(CCCO)NH, 15N-edited NOESY-HSQC, and 13C-
edited aliphatic NOESY-HSQC. The NMR data were recorded
and processed with TopSpin version 3.5, and the data were
analyzed with CARA version 1.5.35 Backbone torsion angles
were predicted using TALOS-N (https://spin.niddk.nih.gov/
bax/software/TALOS-N/)36 and chemical shits of N, HN, Cα,
Cβ, Hα, Hβ, and C′.
Structure Elucidation. NOE distance restraints were
obtained using 15N-edited NOESY-HSQC and 13C-edited
aliphatic NOESY-HSQC. Backbone torsion angles predicted
by TALOS-N36 were used as constraints for structure
calculation, as were the three disulfide bridges Cys420-
Cys440, Cys450-Cys463, and Cys460-Cys462. This informa-
tion enabled structure calculation using CYANA 3.9837,38 by
generating 100 structures that were optimized using 10 000
steps of simulated annealing. Using YASARA39 with a
YASARA force field,40 energy minimization was done on the
20 conformers with lowest CYANA target function values
(Table S1).
Substrate Binding. The interaction between CBM14 and
β-chitin (Mahtani Chitosan, Veraval, Gujarat, India, milled and
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sieved to a particle size of ca. 0.5 mm) was investigated using
NMR spectroscopy. A 15N-HSQC spectrum of 90 μM CBM14
in 50 mM sodium phosphate buffer and 10% D2O, pH 7.0, was
recorded at 25 °C as reference. New 15N-HSQC spectra were
recorded after addition of β-chitin (1, 2, and 6 mg). The
change in chemical shift Δδ (in ppm) was calculated using the
following formula: Δδ = ((ΔδH)2 + (ΔδN/5)2)1/2,41 where
ΔδH and ΔδN are the change in chemical shift for the amide
proton and amide nitrogen (ppm), respectively. The
interaction between CBM14 and (GlcNAc)3 was done as
described by Crasson and co-workers.13
In addition, interaction studies were carried out with the
mutant, 90 μM 15N CBM14 Leu454Ala with two substrates:
(GlcNAc)3 (Seikagaku Corporation, Tokyo, Japan) (12 mM)
and β-chitin (6 mg).
The interaction between CBM14 and (GlcNAc)3 was
studied by saturation transfer difference (STD)-NMR using
the following pulse programs: water LOGSY,21,22 STD,23,24
and T1rho (a spinlock element to measure the T1rho was
incorporated in a normal proton experiment with excitation
sculping for water suppression). The water LOGSY was
performed at 25 °C in a 3 mm NMR tube containing 26 μM
CBM14 and 400 μM (GlcNAc)3 (protein:ligand ratio, 1:15) in
50 mM sodium phosphate buffer and 10% D2O, pH 7.0. For
the STD and T1rho experiments, four different protein:ligand
concentrations (1:100: 3 μM CBM14 and 300 μM (GlcNAc)3;
1:50: 5 μM CBM14 and 260 μM (GlcNAc)3; 3:50: 15 μM
CBM14 and 260 μM (GlcNAc)3; and 1:15: 26 μM CBM14
and 400 μM (GlcNAc)3) were tested at 25 °C. The STD
experiments were also done at 15 °C and tested at different
saturation times (0.40, 0.50, 0.75, 0.80, 1.20, 1.60, 2.00, 2.50,
3.00, 4.00, 5.00 s). The on-resonance frequency was set in the
aliphatic region (0.28, 0.37, and 0.82 ppm), and the off-
resonance frequency at −30 ppm.
Docking. High-ambiguity driven biomolecular docking
(HADDOCK) was used to get further insight into the
interaction between CBM14 and (GlcNAc)3. The docking
was carried out using the Easy interface of HADDOCK 2.2
(https://haddock.science.uu.nl/services/HADDOCK2.2/
haddockserver-easy.html).42 The PDB file containing the
NMR structure of CBM14 and a model of (GlcNAc)3 was
uploaded after being generated by GLYCAM Carbohydrate
builder (glycam.org). Active residues were Trp465 and
Asn466, and passive residues were determined automatically
by HADDOCK as those within a radius of 6.5 Å.
Isothermal Titration Calorimetry. Isothermal titration
calorimetry (ITC) was performed using the VP-ITC system
from Microcal, Inc. (Northampton, MA).19 Buffered solutions
of 20 mM TRIS and 50 mM NaCl, pH 7.5, were thoroughly
degassed prior to experiments to avoid air bubbles in the
calorimeter. An enzyme concentration of 45 μM was used in
the reaction cell with a volume of 1.42 mL and 12 mM
(GlcNAc)3 was used in the ITC syringe. Aliquots of 8 μL were
injected into the reaction cell at 200 s intervals. The stirring
speed was set to be 260 rpm. The titrations were performed at
t = 15 °C and were completed after 40 injections. ITC data
were collected automatically using the Microcal Origin version
7.0 software associated with the VP-ITC system. Prior to
further analysis, all data were corrected for heat of dilution by
subtracting the heat produced by titrating 12 mM (GlcNAc)3
into plain buffer. The fitting of data took place by utilizing a
nonlinear least-squares algorithm using a single-site binding
model employed by the Origin software, yielding the
equilibrium binding association constant (Ka) and the enthalpy
change (ΔHr°). The stoichiometry (n) was set to be 1 based
on the knowledge from the NMR experiments. Errors in Ka
and ΔHr° were obtained as standard deviations from four
individual experiments. Kd, ΔGr°, ΔSr°, and −TΔSr° were
calculated from eq 2, and errors in these parameters were
obtained from propagation of error.
Fluorescence Spectroscopy. The partially denatured
CBM14 was prepared by incubating the protein in 6 M
guanidinium chloride during 24 h at 4 °C. Proteins were used
at 16 μM in 8 mM phosphate (Na2HPO4/NaH2PO4) and 16
mM NaCl buffer, pH 7.5. A Varian Cary Eclipse fluorimeter
was used with the software Scan (version 1.1) to analyze the
intrinsic fluorescence of all of the samples. The device was set
up as follows: Excitation wavelength: 295 nm, measured
wavelengths: 300−400 nm, excitation fast filter: 2.5 nm,
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1H,15N-HSQC spectrum of 13C, 15N-labeled CBM14 (0.
1 mM) (Figure S1); restraints and structural statistics
for the 20 best conformers of CBM14 (PDB ID: 6SO0)
(Table S1); residues involved in β-strands from the
crystal (PDB ID: 5HBF) and NMR structure of CBM14
(Table S2); binding isotherm with theoretical fits
obtained for the titration of (GlcNAc)3 against
CBM14 (Figure S2); chemical shift perturbation for
CBM14 interacting with either β-chitin or (GlcNAc)3
(Figure S3); T1rho 1D
1H NMR spectra of CBM14 and
(GlcNAc)3 (Figure S4); and proposed model of the
interaction between CBM14 and (GlcNAc)3 using
HADDOCK (Figure S5) (PDF)
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